Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label
The FDA now requires all 12 GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, to warn of NAION, a rare cause of sudden vision loss. Here is what the data show.
The FDA now requires all 12 GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, to warn of NAION, a rare cause of sudden vision loss. Here is what the data show.
Advagen Pharma is recalling one lot of metoprolol tartrate 50 mg tablets, about 3.68 million pills, after foreign tablets or capsules were found. What patients should do.
FDA granted HeartBeam Breakthrough Device Designation for its 3D ECG system to help physicians assess suspected heart attacks, including at home.